These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30272400)

  • 1. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Sep; 83(189):48950-3. PubMed ID: 30272400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2005 Apr; 70(63):16935-7. PubMed ID: 15806735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Dec; 76(241):77895-99. PubMed ID: 22175093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Jun; 82(108):26349-51. PubMed ID: 28591974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-transtetrahydrocannabinol (delta-9-THC)] in Schedule II. Interim final rule, with request for comments.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Mar; 82(55):14815-20. PubMed ID: 28355049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2009 Oct; 74(192):51234-6. PubMed ID: 19877370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Apr; 83(77):17486-8. PubMed ID: 30016012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2009 May; 74(97):23789-90. PubMed ID: 19507328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.